Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada
- PMID: 36385491
- PMCID: PMC10028061
- DOI: 10.1002/cam4.5389
Evaluating the impact of COVID-19 on cancer declarations in Quebec, Canada
Abstract
Background: COVID-19 affected healthcare worldwide, limited access to healthcare, and delayed cancer screening and diagnosis. In this study, the effect of the first year of COVID-19 was determined on cancer diagnoses in the province of Quebec, Canada.
Methods: Data were collected from the 13 Quebec Cancer Registry health institutions. Newly diagnosed cancer declarations in the first year of the COVID-19 (April 2020-March 2021) were compared with the reference periods (averages of 3 previous years). The main focus was on four leading cancers: lung, prostate, colorectal, and breast cancers. Generalized regression models with a poisson approximation and interrupted time series (ITS) analysis were used. Underestimated cases were presented in terms of relative risk (RR) and 95% confidence intervals (CI). The changes in the stage-specific counts were also assessed in each of the four cancers. Results were illustrated separately for the first 4 months of the pandemic (first wave).
Findings: This study estimated an overall under-reporting of 15.3% (29,019 vs. 24,584) of declarations. This under-reporting was evident across all age groups above 35 years (p < 0.0001), four primary cancers (p < 0.0001), all stages of cancers (p < 0.0001), and both sexes (p < 0.0001). Based on the relative risks, stage-specific lung cancer counts were underestimated by 5%-34% in the first wave (0%-11% in the first year), prostate cancer by 16%-46% in the first wave (0%-25% in the first year), colorectal cancer 15%-45% in the first wave (0%-24% in the first year), and breast cancer 3%-45% in the first wave and (0%-28% in the first year). However, no stage-IV cancers were statically under-reported compared to the pre-pandemic era and not even in the first wave.
Interpretation: Cancer diagnosis was underestimated due to the COVID-19 pandemic in the first year; this effect was more evident in the first phase of the pandemic in Quebec. Further research is required to determine the accurate burden of the disease in the long term.
Keywords: COVID impact; COVID-19; breast cancer; cancer diagnosis; colorectal cancer; lung cancer; pandemic; prostate cancer; stage shift.
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures
References
-
- Ghebreyesu AT. WHO Director‐General's Opening Remarks at the Media Briefing on COVID‐19. 2020. WHO circular on March 11, 2020, Word Health Organization. Accessed March 28, 2022. https://www.who.int/fr/director‐general/speeches/detail/who‐director‐gen...
-
- McCann D. Ministerial Order 2020–005 by the Minister of Health and Social Services dated March 17 2020. https://cdn‐contenu.quebec.ca/cdn‐contenu/adm/min/sante‐services‐sociaux...
-
- Ministry of Health and Social services, Quebec Government . Système de priorisation pour l'accès à une chirurgie en situation de pandémie. Ministry of Health and Social services, 2021. Accessed March 28, 2022. https://publications.msss.gouv.qc.ca/msss/fichiers/2020/20‐210‐398 W.pdf
-
- Ministry of Health and Social services, Quebec Government . Plan provincial de priorisation des activités cliniques secteur première ligne médicale. Ministry of Health and Social services, 2021. Accessed March 28, 2022. https://publications.msss.gouv.qc.ca/msss/fichiers/directives‐covid/dgau...
-
- Kluge HP. Cancer Services Were Disrupted by up to 50% in all Countries Reporting: a Deadly Impact of COVID‐19. World Health Organization (statement) . 2022. Accessed March 28, 2022. https://www.euro.who.int/en/media‐centre/sections/statements/2022/statem...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
